Jeffrey Paley, Director at Journey Medical Corp (DERM), bought 15,000 shares at $2.98 ($45K) on 2023-10-06, disclosed to the SEC on 2023-10-10.
Open-market purchase of $45k DERM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| DERM | BUY | 2023-09-25 | $89K | — | Filing → |
| ATXI | BUY | 2018-12-12 | $133K | — | Filing → |
| RTRX | SELL | 2014-08-18 | $246K | — | Filing → |